Objectives: Idiopathic rapid eye movement sleep behavior disorder (iRBD) is considered to be a prodromal stage of Parkinson's disease (PD). At PD onset, 40 to 70% of the dopaminergic neurons in the substantia nigra (SN) are already lost. Thus, milder SN damage is expected in participants with iRBD. We aimed to quantify SN damage in participants with iRBD using multimodal magnetic resonance imaging (MRI) and to determine biomarker efficacy in preclinical Parkinsonism. Methods: Nineteen participants with iRBD and 18 controls underwent 3-Tesla MRI, including diffusion tensor imaging, neuromelanin (NM)-sensitive imaging, and T2* mapping. Regions of interest in the SN area were drawn in NM-sensitive and T2-weighted images. The volume and normalized signal intensity in NM-sensitive images, R2*, and diffusion tensor measures were quantified in the SN. Additionally, two raters performed visual analysis of the SN using the NM-sensitive images. Results: Participants with iRBD showed a reduction in the NM-sensitive volume and signal intensity and a decrease in fractional anisotropy (FA) versus controls, but showed no differences in axial, radial, or mean diffusivity or in R2*. For NM-sensitive volume and signal intensity, the receiver operating characteristic analysis discriminated between participants with iRBD and controls with a diagnostic accuracy of 0.86 and 0.79, respectively, whereas the accuracy was 0.77 for FA. The three biomarkers had a combined accuracy of 0.92. The fraction of participants correctly characterized by visual assessment was 0.81. Conclusions: NM-sensitive imaging and FA allowed for the detection of SN damage in participants with iRBD with good diagnostic accuracy. These measures may represent valuable biomarkers for prodromal Parkinsonism.
INTRODUCTION
Participants with idiopathic rapid eye movement (REM) sleep behavior disorder (iRBD) display violent behaviors associated with a loss of normal muscle atonia during REM sleep, without daytime motor disorders. Longitudinal studies indicate that most of the participants with iRBD will eventually develop a neurodegenerative disease-generally Parkinson's disease (PD) or dementia with Lewy bodies (DLB)-with a median conversion time of 7 years.
1,2 The motor signs appear progressively, beginning with loss of facial mimicry, reduced speed in motor tests and, later, a mild Parkinsonism. 3 At PD onset, 40 to 70% of the dopaminergic neurons in the substantia nigra (SN) are already lost. 4 Therefore, as most of the participants with iRBD are in a prodromal stage of Parkinsonism, SN damage should be evident. Several imaging studies have indeed suggested that the SN is impaired in participants with iRBD. Transcranial sonography studies revealed abnormal hyperechogenicity of the SN in iRBD. 5, 6 Recent magnetic resonance imaging (MRI) studies identified a loss of dorsolateral nigral hyperintensity, 7 diffusion tensor imaging (DTI) modifications, 8, 9 and a disruption of basal ganglia connectivity in iRBD, similar to what is observed in PD. 10 In PD, SN damage has been characterized using MR techniques, such as neuromelanin (NM)-sensitive imaging, 11, 12 iron imaging with R2* increase, 13 ,14 DTI alteration 15 , or combinations of multiple biomarkers. 16, 17 Changes in these MRI markers were significant even at early stages of the disease, 13, 18 suggesting potential preclinical damage. Here, we studied SN damage in participants with iRBD using the above markers to determine which combination can best characterize the SN damage in participants with iRBD and distinguish them from healthy controls (HC).
METHODS

Participants
Twenty-one participants with iRBD were consecutively included in the Sleep Disorders Unit of the Pitie-Salpetriere
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hospital from January to November 2014. All the patients met the international diagnostic criteria (American Academy of Sleep Medicine, 2014) and had polysomnography-confirmed iRBD. The exclusion criteria were the presence of definite criteria for Parkinsonism, 19 dementia, which absence was accessed by a Mini-Mental State Examination > 26 and Montreal Cognitive Assessment score > 23, other neurodegenerative disorders, secondary RBD, or factors preventing MRI examination. For comparison, 21 age-and gender-matched HC were included. The exclusion criteria for HC were a history of neurological disorders, dementia, RBD, or a percentage of REM sleep without atonia greater than 15%. All participants provided written informed consent. The local ethics committee approved the study. Participants in the present study have previously been reported. 20 
Clinical Analysis
All participants underwent a clinical examination, including, at minimum, motor, cognitive, and autonomous tests. 20 Motor disability was measured using the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS). 21 Global disability was evaluated using Hoehn and Yahr (HY) staging.
MRI Data Acquisition
MR acquisition was performed using a 3-Tesla whole-body TRIO 32-channel TIM system (Siemens) using a 12-channel receiver head coil. The protocol included high-resolution three-dimensional (3D) T1-weighted (T1-w) whole-brain anatomical images, 3D T2-weighted (T2-w) images, NM-sensitive T1-w images, DTI, and R2* mapping. Three-dimensional T1-w scans were acquired using sagittal magnetization prepared rapid gradient echo acquisition (inversion time: 900 ms, repetition time (TR)/echo time (TE): 2300 ms/4.18 ms, flip angle: 9°, voxel size: 1 × 1 × 1 mm 3 , 1 average). The T2-w turbo-spin-echo sequence was acquired with TR/TE/flip angle: 3000 ms/4.28 ms/120° and voxel size: 1.1 × 1.1 × 1.1 mm 3 . NM-sensitive images were acquired using two-dimensional (2D) axial turbo spin echo T1-w images (TR/TE/flip angle: 900 ms/15 ms/180°, voxel size: 0.4 × 0.4 × 3 mm 3 , 3 averages). The DTI parameters were TR/TE/flip angle: 14000 ms/101 ms/90°, b-value: 1500 s/mm 2 , voxel size: 1.7 × 1.7 × 1.7 mm 3 , and 60 diffusion gradient directions. R2* mapping was computed using a gradient-echo planar sequence with 6 TEs (range, 24 to 94 ms), TR/flip angle: 9000/90°, and voxel size: 2 × 2 × 2 mm 3 .
Image Analysis
Image processing and analysis were performed with software written in-house in MATLAB (The MathWorks, Inc., Natick, MA, USA) and with SPM8 (http://www.fil.ion.ucl.ac.uk/spm/ software/spm8/), Freesurfer (http://freesurfer.net/, MGH, Boston, MA, USA), and FMRIB Software Library (FSL) v5.0 (FMRIB Analysis Group, Oxford, UK).
Regions of Interest Selection
The contours of the SN were drawn manually using FreeSurfer on the basis of the most intense signal area on the NM-sensitive images (Figure 1) , considered, based on previous studies to include mainly the SN pars compacta (SNpc). [22] [23] [24] Additionally, the SN was also drawn on the T2-w images, considered to include mainly the SN pars reticulata (SNpr). On T2-w images, the regions were first defined on the coronal images and then corrected on sagittal and axial images. The SN was defined as the hypointense area dorsal to the cerebral peduncle and ventral to the red nucleus. 23 The subthalamic nucleus (STN) was also segmented to avoid confusion between the SN and the STN. One expert rater drew the SN contours manually, blinded to the status of the participants. To evaluate the accuracy of segmentation, 10 randomly selected patients were evaluated twice for by a second expert rater blinded to the status of the participants and to the segmentation of the first rater. The concordance between the segmentations was good, (Dice similarity coefficient = 0.8).
Quantitative Analysis of NM-Sensitive Images
The NM-based SN volumes were calculated using in-house MATLAB algorithms. The signal ratio was calculated by normalizing the mean signal of the SN in each slice by the signal in the background region. The background region was traced manually on the same slices as the SN on native images, including the tegmentum and the superior cerebellar peduncles ( Figure 1 ).
Diffusion Imaging
DTI, NM-sensitive, and T2-w images were linearly coregistered to the 3D T1-w volume using the SPM coregister function. Standard preprocessing of the DTI acquisition was performed using FSL v5.0. Motion and eddy currents were corrected using the eddycor function. A standard field map acquisition was used to correct for echo-planar deformation. Fractional anisotropy (FA), axial diffusivity (AD), radial diffusivity (RD), and mean diffusivity (MD) maps were then computed for the entire volume in FSL with the DTI fit function. Finally, the mean value of each measure was computed in the SN regions of interest (ROIs) drawn both on NM-sensitive images and on T2-w images (NM-sensitive SN ROI and T2-w SN ROI).
Quantitative Measurements of R2*
The images for each TE were realigned, normalized, and coregistered, and T2* maps were calculated by fitting the data to the logarithmic signal decay over all 6 TEs. The T2-w and NM-based ROIs of the SN were coregistered and resliced to R2* map spaces in SPM8 using nearest-neighbor interpolation. The mean R2* value was calculated over each ROI.
Blinded Visual Analysis of the Nm-Sensitive Signal
Two raters visually analyzed the SN signal intensity in the NM-sensitive images. The scans were classified using a 2-point scale as follows: (1) normal aspect of the SN with a high bilateral signal intensity and no volume loss, indicating HC (2) abnormal aspect with uni-or bilateral signal reduction or volume loss of the SN, indicating a patient. Each reader analyzed all of the images twice, in random order. There was no time limit for the visual evaluations. In the case of conflicting cases, an agreement between the raters was reached.
Statistical Analysis
The measurements and clinical variables were compared between groups using the Mann-Whitney U test. For significant differences, a diagnostic value was estimated using receiver operating characteristic (ROC) analysis, and the sensitivity and specificity of the cut-off point were estimated using the Youden index. A five-fold cross-validation was used to estimate the area under the curve with the corresponding standard error and the confidence interval for each combination. Inter-and intrarater agreements for the qualitative measurements were estimated using the Cohen kappa coefficient. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for each marker. The diagnostic accuracy of each measurement was considered "excellent" between 0.9 and 1, "good" between 0.80 and 0.90, and "fair" between 0.70 and 0.80 accuracy. A patient group study was conducted to investigate associations between the general clinical measures (HY staging, MDS-UPDRS, and disease duration) and the MRI measurements. To control for age and gender, partial correlations followed by a multiple comparisons permutation approach were used to test for the significance of the correlation coefficients.
RESULTS
Simple Characterization
Two participants with iRBD and 3 HC were excluded because the NM-sensitive acquisition volume did not contain the SN due to incorrect slice positioning. Consequently, 19 participants with iRBD (mean age 67.3 ± 8.0 years, 15 males) and 18 HC (mean age 66.5 ± 5.1 years, p = .73 vs. participants with iRBD; 14 males, p = .93 vs. participants with iRBD) were analyzed. The mean disease duration was 5.7 ± 3.8 years; the UPDRS III scores were 2.7 ± 2.4 for patients and 0.7 ± 1.2 for HC (p = .01).
The detailed clinical data are presented in Supplementary  Table 1 .
MRI Data Analysis
There were no significant differences in the T2-w SN ROI volumes between iRBD and HC (p = .57, Table 1 ).
NM-Sensitive Results
SN volume.
The average SNpc volume in participants with iRBD was lower than that in HC (p = .0003, Table 1, Figure 2A) .
The ROC analysis showed a good discrimination between the iRBD and HC groups ( Table 2 ; cut-off point = 171.5, Figure 3A ).
SN signal.
The average SNpc signal in participants with iRBD was lower than that in HC (p = .005, Table 1, Figure 2B ). The ROC analysis showed a good discrimination between iRBD and HC (Table 2 ; cut-off point = 12.4, Figure 3A ).
Combined SN signal and volume. There was no significant correlation between signal and volume changes (r = 0.36, p = .14). The diagnostic accuracy of a combination of the volume and signal assessments, assessed using a binomial logistic regression model, was 0.86. The predicted probability values of the model were used to fit a ROC curve (Table 2, Figure 3B ). 
Visual assessment results.
The analysis by the two readers who performed the evaluations showed a good discrimination between iRBD and HC, with good diagnostic accuracy ( Table 2) . The Cohen's kappa coefficient was calculated to evaluate the inter-rater agreement. There was good agreement between the two raters (κ = 0.81, 95% CI 0.69-0.94, p < .001).
DTI Results
There was no significant difference between the T2-w SN ROI volumes between iRBD and HC (p = .57).
The average FA in the NM-sensitive SN ROI was lower in the iRBD group than in the HC group (p = .005, Table 1, Figure 2C ), whereas there was no difference for AD (p = .5), RD (p = .38), or MD (p = .87). The ROC analysis showed fair discrimination between iRBD and HC for FA (Table 2 , cut-off point = 0.33, Figure 3A ). There was no difference between the iRBD and HC groups in the T2-w SN ROI for any DTI parameter ( Table 1) .
Combination of SN Signal, Volume, and FA
The diagnostic accuracy of a combination of the volume and signal assessments and the FA mean value in the NM-sensitive SN ROI, estimated using a logistic regression model, was 0.92.
The predicted probability values of the model were used to fit a ROC curve (Table 2, Figure 3B ). There were no significant differences between the AUC of the combination of NM-sensitive signal and volume and the combination of the NM-sensitive signal and volume with the FA. A logistic regression model was used to determine the best combination of variables that optimized the AUC and the sensitivity and specificity. The logistic regression model was statistically significant, with X 2 (3) = 37.85 and p < .0001. The model explained 85% of the variance (Nagelkerke R 2 ) and correctly classified 89.2% of the participants. The sensitivity was 89.4%, and the specificity was 88.8%. Of the three predictive variables, NM-sensitive volume and FA were statistically significant.
R2* Results
There was no difference between the iRBD and HC groups in the R2* results for the SN, for the NM-sensitive SN ROIs or for the T2-w SN ROIs.
Clinical Correlations
There was a weak correlation between the FA in the left SN (with the NM-sensitive SN ROI) and the disease duration 
DISCUSSION
We observed significant decreases in the NM-sensitive volume and signal intensity and in the FA of the SN in participants with iRBD as compared with HC. Moreover, the combination of these measurements showed an excellent diagnostic accuracy.
Our finding of SN damage in iRBD is consistent with previous positron emission tomography (PET) and single-photon emission tomography (SPECT) studies that identified a subtle presynaptic dopaminergic denervation in participants with iRBD in the absence of fully developed Parkinsonism. Studies with markers of dopamine transporter integrity 23, 25 have shown a decreased nigro-striatal dopaminergic function in participants with iRBD. The presence of nigro-striatal dopaminergic deafferentation in participants with iRBD was confirmed using other dopamine transporter markers with SPECT 26 and PET. [27] [28] [29] We observed decreases in both the NM-sensitive volume and signal intensity in the SN of participants with iRBD. To the best of our knowledge, this is the first study to investigate the loss of NM signals in the SN in iRBD. NM is a pigment, presenting in catecholaminergic neurons, which has paramagnetic T1-shortening effects; therefore, the NM signal alteration in the SN of participants with iRBD is expected to be associated with a subclinical dopaminergic deficit. Loss of the NM signal has been reported in the coeruleus-subcoeruleus complex in participants with iRBD 30 and PD, 31 and this signal loss was proportional to atonia during REM sleep. Indeed, the loss of NM signal intensity in iRBD complements the results of previous studies showing decreases in NM-sensitive volume and signal in participants with PD, even at early stages of the disease. 12, 32 The reduction in signal intensity had a slightly lower diagnostic accuracy than the reduction in volume, which also corroborates previous studies of PD. 33 Although there was no correlation between signal intensity and volume decrease, the combination of the two markers may increase the diagnostic accuracy. Overall, the SN signal intensity and volume reductions in iRBD were consistent with those observed in early PD, supporting the hypothesis that iRBD is a premotor PD stage. 32 Visual evaluation of the loss of NM signal intensity and volume in the SN showed excellent specificity (95%) but lower sensitivity (67%). Visual evaluation allowed the correct characterization of two-thirds of patients and nearly all of the HC, suggesting this technique has a value in routine clinical screenings.
FA decreased bilaterally in the SN of participants with iRBD in the absence of accompanying changes in the other DTI measures, in accord with previous studies of PD. 15 Altered SN microstructural integrity in several cortical and subcortical regions was also observed in a previous study of participants with iRBD, although it was restricted to an isolated decrease in AD. 9 Although FA was reduced in the NM-sensitive SN ROIs that mainly corresponded to the SNpc, no changes were detected in the T2-w SN ROIs (corresponding mainly to the SNpr), 23 consistent with the predominant involvement of the SNpc in PD, as shown previously. 24, 34 In addition, a recent study suggested that DTI performance might be improved using advanced diffusion models that separate free water and tissue diffusion. 35 Both the NM-sensitive volume and signal and the FA biomarkers were more specific than they were sensitive. Most HC were correctly characterized, whereas SN damage was found in only 67% of the participants with iRBD using FA and 79% using the NM-sensitive volume. However, the combination of all three biomarkers allowed for the correct detection of 90% of the patients.
Among 2-biomarker combinations, NM-sensitive volume and FA were more efficient than NM-sensitive volume and signal, with the correct characterization of 89% of participants. This difference was likely due to redundancy between the NM-sensitive volume and signal biomarkers, whereas FA gave additional information about microstructural damage. The fraction of participants with iRBD in our study with SN damage was higher than the fraction of participants with iRBD (twothirds) presenting with a loss of dorsolateral nigral hyperintensity in a previous study. 7 The fraction previously observed by means of PET and SPECT was variable across studies, ranged from one-third to all the participants. [25] [26] [27] [28] [29] The combination of SPECT with transcranial sonography may also increase the number of correctly characterized participants. 5 Comparative studies of these various biomarkers will be necessary to better characterize these differences and determine the added value of their combination.
We found no significant R2* increase in participants with iRBD. An increase was expected, as R2* correlates with iron concentration, and increased iron concentration had been reported in iRBD based on transcranial sonography. 5 In addition, R2* increases have previously been found in asymptomatic carriers of the LRRK2 and Parkin mutations, which are the risk factors for PD. 36 The lack of an R2* increase might be explained by the high mean age of our sample (67 years), as R2* increases with age in both patients and controls. Moreover, no significant increase in R2* values in iRBD was also found in a previous study. 37 However, studies with better spatial resolution and improved techniques, such as quantitative susceptibility mapping, 38 are needed to further evaluate this finding. There was a weak correlation between disease duration and FA in the left SN. We found no significant correlation for the right SN. Some previous studies have also reported predominant changes in the right or the left hemisphere alternatively in participants with either iRBD 9 or PD, 17, 39 suggesting that this predominance is a characteristic of the population studied probably associated with the well-known asymmetry of the motor symptoms in the early stages of the disease. There was no correlation between disease duration and the NM-sensitive volume or signal values. Correlations between SN damage and clinical markers such as duration or UPDRS are inconsistent in the literature, as they are present in some studies 16, 24 and absent in others; 17 therefore, longitudinal studies are needed to better understand the dynamics of changes in SN imaging biomarkers. The MRI markers did not correlate with the motor disability score or with a loss of muscle atonia during REM sleep. These results were expected, as the MDS-UPDRS score was low in the iRBD group (floor effect), even if it was significantly higher than that in the HC group, and because the loss of muscle atonia during REM sleep is not directly related to SN damage but rather to damage in the coeruleus/subcoeruleus complex. 20, 31 The identification of a neurodegenerative brainstem process using routinely available MRI methods would be valuable for the early detection of premotor PD. According to the Braak model of PD, α-synuclein deposition in the medulla oblongata and pons should occur earlier than in the SN in presymptomatic patients. 40 We observed damage in the coeruleus-subcoeruleus complex in the same participants with iRBD. 20 Future studies of other brainstem regions should yield insights into the progression of brainstem damage in participants with iRBD.
Our study had several limitations. First, the cross-sectional design did not allow us to determine whether the patients would actually develop Parkinsonism. Second, our sample size was relatively small, and our results require confirmation in larger cohorts. Third, DAT-SPECT was not performed in our study. Future studies comparing DAT-SPECT and NM-sensitive MRI are needed to investigate the relationship between the NM loss and the striatal dopaminergic denervation. Longitudinal studies will be also useful in this context to show the differences in the dynamics of the progression between these two markers. Finally, studies about the involvement of other regions, such as the medulla oblongata or pons, and their correlation with clinical parameters are needed.
In summary, the SN damage in iRBD was observed using NM-sensitive imaging and FA. The combination of NM-sensitive volume and signal intensity with the FA measurements showed excellent diagnostic accuracy, allowing the detection of SN damage in a large fraction of participants with iRBD. Longitudinal studies are needed to determine whether these measurements may be the valuable biomarkers of prodromal PD or other forms of Parkinsonism.
